Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Käck

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|May 2, 2015
Successful generation of structural information for fragment-based drug discoveryLinda Öster, Sofia Tapani, Yafeng Xue, et al.
Expert Opinion on Drug Discovery|December 24, 2025
Protein crystallization strategies in structure-based drug designMargareta Ek, Linda Öster, Helena Käck, et al.
European Journal of Medicinal Chemistry|November 6, 2021
Discovery and optimization of cyclohexane-1,4-diamines as allosteric MALT1 inhibitorsStefan Schiesser, Peter Hajek, Huw E Pople, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2012
Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabiltyGregory S Basarab, Pamela Hill, Charles J Eyermann, et al.
Scientific Reports|June 15, 2022
Machine learning/molecular dynamic protein structure prediction approach to investigate the protein conformational ensembleMartina Audagnotto, Werngard Czechtizky, Leonardo De Maria, et al.
The Journal of Biological Chemistry|March 20, 2024
The structures of salt-inducible kinase 3 in complex with inhibitors reveal determinants for binding and selectivityLinda Öster, Marie Castaldo, Emma de Vries, et al.
ACS Medicinal Chemistry Letters|August 16, 2019
DPP1 Inhibitors: Exploring the Role of Water in the S2 Pocket of DPP1 with Substituted PyrrolidinesHelena Käck, Kevin Doyle, Samantha J Hughes, et al.
Chemical Science|October 13, 2023
A cell-active cyclic peptide targeting the Nrf2/Keap1 protein-protein interactionJessica Iegre, Sona Krajcovicova, Anders Gunnarsson, et al.
Journal of Medicinal Chemistry|November 9, 2017
X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase InhibitorsMichael R Witten, Lisa Wissler, Melanie Snow, et al.
Journal of Medicinal Chemistry|October 4, 2016
Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)Kevin Doyle, Hans Lönn, Helena Käck, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|May 2, 2015
Successful generation of structural information for fragment-based drug discoveryLinda Öster, Sofia Tapani, Yafeng Xue, et al.
Expert Opinion on Drug Discovery|December 24, 2025
Protein crystallization strategies in structure-based drug designMargareta Ek, Linda Öster, Helena Käck, et al.
European Journal of Medicinal Chemistry|November 6, 2021
Discovery and optimization of cyclohexane-1,4-diamines as allosteric MALT1 inhibitorsStefan Schiesser, Peter Hajek, Huw E Pople, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2012
Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabiltyGregory S Basarab, Pamela Hill, Charles J Eyermann, et al.
Scientific Reports|June 15, 2022
Machine learning/molecular dynamic protein structure prediction approach to investigate the protein conformational ensembleMartina Audagnotto, Werngard Czechtizky, Leonardo De Maria, et al.
The Journal of Biological Chemistry|March 20, 2024
The structures of salt-inducible kinase 3 in complex with inhibitors reveal determinants for binding and selectivityLinda Öster, Marie Castaldo, Emma de Vries, et al.
ACS Medicinal Chemistry Letters|August 16, 2019
DPP1 Inhibitors: Exploring the Role of Water in the S2 Pocket of DPP1 with Substituted PyrrolidinesHelena Käck, Kevin Doyle, Samantha J Hughes, et al.
Chemical Science|October 13, 2023
A cell-active cyclic peptide targeting the Nrf2/Keap1 protein-protein interactionJessica Iegre, Sona Krajcovicova, Anders Gunnarsson, et al.
Journal of Medicinal Chemistry|November 9, 2017
X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase InhibitorsMichael R Witten, Lisa Wissler, Melanie Snow, et al.
Journal of Medicinal Chemistry|October 4, 2016
Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)Kevin Doyle, Hans Lönn, Helena Käck, et al.
Pageof 2